Enanta Pharmaceuticals, Inc.ENTANASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank20
3Y CAGR-63.5%
5Y CAGR-31.4%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
-63.5%/yr
vs -8.4%/yr prior
5Y CAGR
-31.4%/yr
Recent deceleration
Acceleration
-55.1pp
Decelerating
Percentile
P20
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $302000.00 | -83.2% |
| 2025 | $1.80M | -53.9% |
| 2024 | $3.90M | -37.2% |
| 2023 | $6.21M | +275.1% |
| 2022 | $1.66M | -17.0% |
| 2021 | $1.99M | -69.9% |
| 2020 | $6.62M | -24.9% |
| 2019 | $8.82M | +84.0% |
| 2018 | $4.79M | +105.4% |
| 2017 | $2.33M | - |